Cedar Brook Financial Partners »

AstraZeneca shares owned by Cedar Brook Financial Partners

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Cedar Brook Financial Partners from 13F filings

Historical chart of Cedar Brook Financial Partners investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Cedar Brook Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Cedar Brook Financial Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $841k 12k 67.75
2023-12-31 $863k 13k 69.18
2023-09-30 $887k 13k 67.72
2023-06-30 $931k 13k 71.57
2023-03-31 $944k 14k 69.41
2022-12-31 $898k 13k 67.80
2022-09-30 $658k 12k 54.84
2022-06-30 $724k 11k 66.06
2022-03-31 $764k 12k 66.31
2021-12-31 $653k 11k 58.24
2021-09-30 $653k 11k 60.09
2021-06-30 $611k 10k 59.92
2021-03-31 $467k 9.4k 49.68
2020-12-31 $409k 8.2k 49.95
2020-09-30 $392k 7.2k 54.79
2020-06-30 $373k 7.0k 52.96
2020-03-31 $321k 7.2k 44.66
2019-12-31 $380k 7.6k 49.84
2019-09-30 $347k 7.8k 44.57
2019-06-30 $285k 6.9k 41.21
2019-03-31 $269k 6.7k 40.40